Polar Capital Holdings’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.3M	Sell	5,654,340 -2,277,063	-29%	-$10.6M	0.09%	130
2025 Q4	$43.6M	Buy	7,931,403 +2,637,524	+50%	+$12.8M	0.17%	107
2025 Q3	$17.3M	Buy	5,293,879 +293,879	+6%	+$832K	0.08%	165
2025 Q2	$11.6M	Buy	5,000,000 +2,000,000	+67%	+$4.35M	0.06%	178
2025 Q1	$4.17M	Hold	3,000,000	–	–	0.03%	238
2024 Q4	$5.19M	Sell	3,000,000 -25,000	-0.8%	-$51.9K	0.03%	247
2024 Q3	$6.08M	Hold	3,025,000	–	–	0.03%	233
2024 Q2	$6.78M	Buy	3,025,000 +506,091	+20%	+$1.47M	0.04%	217
2024 Q1	$7.23M	Hold	2,518,909	–	–	0.04%	221
2023 Q4	$4.46M	Sell	2,518,909 -11,091	-0.4%	-$22.1K	0.03%	237
2023 Q3	$7.99M	Buy	+2,530,000	New	+$4.73M	0.06%	202